Cite
HARVARD Citation
Nappi, A. et al. (2017). Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist. Infectious agents and cancer. 12 (1), pp. 1-6. [Online].